<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39410001</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 Pandemic and Lockdown on Cancer Diagnoses Using Swiss Cantonal Cancer Registry Data.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3381</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers16193381</ELocationID><Abstract><AbstractText><b>Background/Objectives:</b> This study aims to investigate differences in cancer diagnosis based on absolute case numbers and age-standardized incidence rate ratios (IRRs) in the pre-Coronavirus disease 2019 (COVID-19) years (2018/19) and the first two years of the COVID-19 pandemic (2020, 2021) in two Swiss cantons. <b>Methods</b>: Data of the Swiss cantonal cancer registry of the cantons of Zurich (ZH) and Zug (ZG) were used to descriptively investigate differences in annual and monthly absolute numbers regarding all-cancer and the five most common cancer types. Directly age-standardized monthly incidence rates (IRs) were calculated. Multivariate Quasipoisson regression models were fitted to determine the IRRs with 95% confidence intervals (95% CI). <b>Results</b>: Annual absolute numbers of all investigated cancers were similar in 2018/19, 2020, and 2021, except for prostate cancer (increase of 20.8% in 2021 compared to 2018/19). In 2020, there were generally more cancer diagnoses in January and February followed by a decrease in April and May. Compared to the pre-COVID-19 period, lower IRs were observed in 2020 for all-cancer (IRR = 0.96 [95% CI 0.96, 0.97]) and female breast cancer (0.92 [0.89, 0.96]), whereas higher IRs were observed in 2021 for all-cancer (1.02 [1.02, 1.02]) and prostate cancer (1.23 [1.18, 1.28]). <b>Conclusions</b>: Cancer detection and diagnoses decreased during the first year of the pandemic, especially during the most stringent lockdown phase in April. The findings of this study may inform the decisions of policymakers and public health system during future pandemics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suter</LastName><ForeName>Flurina</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5302-2268</Identifier><AffiliationInfo><Affiliation>Division of Chronic Disease Epidemiology, Department of Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, 8001 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanner</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0888-0690</Identifier><AffiliationInfo><Affiliation>Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8006 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menges</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Chronic Disease Epidemiology, Department of Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, 8001 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wicki</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2924-8080</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology and Hematology, Faculty of Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korol</LastName><ForeName>Dimitri</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9217-8038</Identifier><AffiliationInfo><Affiliation>Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8006 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohrmann</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2215-1200</Identifier><AffiliationInfo><Affiliation>Division of Chronic Disease Epidemiology, Department of Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, 8001 Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8006 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KFS-5731-02-2023</GrantID><Agency>Swiss Cancer Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Switzerland</Keyword><Keyword MajorTopicYN="N">cancer registry</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">directly age-standardized cancer incidence rate</Keyword><Keyword MajorTopicYN="N">regression analysis</Keyword></KeywordList><CoiStatement>D.M. received funding for a different cancer-related project from the Swiss Cancer Foundation (SCF), the Arnold U. und Susanne Huggenberger-Bischoff Stiftung, and one further, private, not-for-profit research foundation from Switzerland requesting anonymity. Otherwise, no conflicts of interest exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39410001</ArticleId><ArticleId IdType="pmc">PMC11482598</ArticleId><ArticleId IdType="doi">10.3390/cancers16193381</ArticleId><ArticleId IdType="pii">cancers16193381</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO) Chinese Research Team . WHO-Convened Global Study of Origins of SARS-CoV-2: China Part. World Health Organization (WHO); Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Umakanthan S., Sahu P., Ranade A., Bukelo M.M., Rao J.S., Abrahao-Machado L.F., Dahal S., Kumar H., Kv D. Origin, Transmission, Diagnosis and Management of Coronavirus Disease 2019 (COVID-19) Postgrad. Med. J. 2020;96:753–758. doi: 10.1136/postgradmedj-2020-138234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138234</ArticleId><ArticleId IdType="pmc">PMC10016932</ArticleId><ArticleId IdType="pubmed">32563999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A.Y., Cullen M.R., Harrington R.A., Barry M. The Impact of Novel Coronavirus COVID-19 on Noncommunicable Disease Patients and Health Systems: A Review. J. Intern. Med. 2021;289:450–462. doi: 10.1111/joim.13184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13184</ArticleId><ArticleId IdType="pmc">PMC7675448</ArticleId><ArticleId IdType="pubmed">33020988</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Office of Public Health (FOPH)  Coronavirus: Bundesrat Erklärt Die “Ausserordentliche Lage” Und Verschärft Massnahmen.  [(accessed on 30 January 2024)].  Available online:  https://www.bag.admin.ch/bag/de/home/das-bag/aktuell/medienmitteilungen.msg-id-78454.html.</Citation></Reference><Reference><Citation>Federal Office of Public Health (FOPH)  Coronavirus: Rückkehr in Die Normale Lage Und Planung Der Übergangsphase Bis Frühling. 2023.  [(accessed on 31 January 2024)].  Available online:  https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-87801.html.</Citation></Reference><Reference><Citation>Swiss Cancer Screening  Geschäftsbericht 2020.  [(accessed on 30 January 2024)].  Available online:  https://www.swisscancerscreening.ch/fileadmin/user_upload/scs_Gescha__ftsbericht_DE_2020_210707.pdf.</Citation></Reference><Reference><Citation>Neamţiu L., Martos C., Giusti F., Negrão Carvalho R., Randi G., Dimitrova N., Flego M., Dyba T., Bettio M., Gavin A., et al. Impact of the First Wave of the COVID-19 Pandemic on Cancer Registration and Cancer Care: A European Survey. Eur. J. Public Health. 2022;32:311–315. doi: 10.1093/eurpub/ckab214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckab214</ArticleId><ArticleId IdType="pmc">PMC8975538</ArticleId><ArticleId IdType="pubmed">34935934</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner H., Cardoso R., Heisser T., Hoffmeister M., Holleczek B. Indications of Substantial Delay of Colorectal Cancer Diagnoses Due to COVID-19 in Germany. Lancet Reg. Health Eur. 2022;23:100543. doi: 10.1016/j.lanepe.2022.100543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100543</ArticleId><ArticleId IdType="pmc">PMC9646477</ArticleId><ArticleId IdType="pubmed">36381140</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene G., Griffiths R., Han J., Akbari A., Jones M., Lyons J., Lyons R.A., Rolles M., Torabi F., Warlow J., et al. Impact of the SARS-CoV-2 Pandemic on Female Breast, Colorectal and Non-Small Cell Lung Cancer Incidence, Stage and Healthcare Pathway to Diagnosis during 2020 in Wales, UK, Using a National Cancer Clinical Record System. Br. J. Cancer. 2022;127:558–568. doi: 10.1038/s41416-022-01830-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-022-01830-6</ArticleId><ArticleId IdType="pmc">PMC9060409</ArticleId><ArticleId IdType="pubmed">35501391</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini M., Teglia F., Astolfi L., Casolari G., Boffetta P. Decrease of Cancer Diagnosis during COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Eur. J. Epidemiol. 2023;38:31–38. doi: 10.1007/s10654-022-00946-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00946-6</ArticleId><ArticleId IdType="pmc">PMC9807424</ArticleId><ArticleId IdType="pubmed">36593334</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojanowski M., Radomyski P., Kycler W., Michalek I.M. Decrease in the Number of New Cancer Diagnoses during the First Year of the COVID-19 Pandemic—Cohort Study of 3.5 Million Individuals in Western Poland. Front. Oncol. 2023;13:1230289. doi: 10.3389/fonc.2023.1230289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2023.1230289</ArticleId><ArticleId IdType="pmc">PMC10765942</ArticleId><ArticleId IdType="pubmed">38179170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribes J., Pareja L., Sanz X., Mosteiro S., Escribà J.M., Esteban L., Gálvez J., Osca G., Rodenas P., Pérez-Sust P., et al. Cancer Diagnosis in Catalonia (Spain) after Two Years of COVID-19 Pandemic: An Incomplete Recovery. ESMO Open. 2022;7:100486. doi: 10.1016/j.esmoop.2022.100486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.esmoop.2022.100486</ArticleId><ArticleId IdType="pmc">PMC9197337</ArticleId><ArticleId IdType="pubmed">35714476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman H.W., Chen Z., Niles J., Fesko Y. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Netw. Open. 2020;3:e2017267. doi: 10.1001/jamanetworkopen.2020.17267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.17267</ArticleId><ArticleId IdType="pmc">PMC7403918</ArticleId><ArticleId IdType="pubmed">32749465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostner L., Cerminara S.E., Pamplona G.S.P., Maul J.T., Dummer R., Ramelyte E., Mangana J., Wagner N.B., Cozzio A., Kreiter S., et al. Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers. 2022;14:2360. doi: 10.3390/cancers14102360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14102360</ArticleId><ArticleId IdType="pmc">PMC9139530</ArticleId><ArticleId IdType="pubmed">35625961</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi Zadeh S.M., Tajik F., Gheytanchi E., Kiani J., Ghods R., Madjd Z. COVID-19 Pandemic Impact on Screening and Diagnosis of Prostate Cancer: A Systematic Review. BMJ Support. Palliat. Care. 2023 doi: 10.1136/spcare-2023-004310. spcare-2023-004310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/spcare-2023-004310</ArticleId><ArticleId IdType="pubmed">37748857</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock H.M., De Gendt C., Silversmit G., Nuyts S., Casselman J., Machiels J.P., Giusti F., van Gool B., Vander Poorten V., Van Eycken L. Stage Shift and Relative Survival for Head and Neck Cancer during the 2020 COVID-19 Pandemic: A Population-Based Study of Temporal Trends. Front. Oncol. 2023;13:1253968. doi: 10.3389/fonc.2023.1253968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2023.1253968</ArticleId><ArticleId IdType="pmc">PMC10548264</ArticleId><ArticleId IdType="pubmed">37799467</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke J.P., Von Elm E., Altman D.G., Gøtzsche P.C., Mulrow C.D., Pocock S.J., Poole C., Schlesselman J.J., Egger M. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. PLoS Med. 2007;4:1628–1654. doi: 10.1371/journal.pmed.0040297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040297</ArticleId><ArticleId IdType="pmc">PMC2020496</ArticleId><ArticleId IdType="pubmed">17941715</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Office of Public Health (FOPH)  Gesetzgebung Krebsregistrierung.  [(accessed on 1 February 2024)].  Available online:  https://www.bag.admin.ch/bag/de/home/gesetze-und-bewilligungen/gesetzgebung/gesetzgebung-mensch-gesundheit/gesetzgebung-krebsregistrierung.html.</Citation></Reference><Reference><Citation>World Health Organization  ICD-10 Version: 2019—International Statistical Classification of Diseases and Related Health Problems 10th Revision.  [(accessed on 18 November 2022)].  Available online:  https://icd.who.int/browse10/2019/en.</Citation></Reference><Reference><Citation>Hale T., Angrist N., Goldszmidt R., Kira B., Petherick A., Phillips T., Webster S., Cameron-Blake E., Hallas L., Majumdar S., et al. A Global Panel Database of Pandemic Policies (Oxford COVID-19 Government Response Tracker) Nat. Hum. Behav. 2021;5:529–538. doi: 10.1038/s41562-021-01079-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01079-8</ArticleId><ArticleId IdType="pubmed">33686204</ArticleId></ArticleIdList></Reference><Reference><Citation>Fay M.P., Feuer E.J. Confidence Intervals for Directly Standardized Rates: A Method Based on the Gamma Distribution. Stat. Med. 1997;16:791–801. doi: 10.1002/(SICI)1097-0258(19970415)16:7&lt;791::AID-SIM500&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0258(19970415)16:7&lt;791::AID-SIM500&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">9131766</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team  The R Project for Statistical Computing.  [(accessed on 18 November 2022)].  Available online:  https://www.r-project.org/</Citation></Reference><Reference><Citation>Peacock H.M., Tambuyzer T., Verdoodt F., Calay F., Poirel H.A., De Schutter H., Francart J., Van Damme N., Van Eycken L. Decline and Incomplete Recovery in Cancer Diagnoses during the COVID-19 Pandemic in Belgium: A Year-Long, Population-Level Analysis. ESMO Open. 2021;6:100197. doi: 10.1016/j.esmoop.2021.100197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.esmoop.2021.100197</ArticleId><ArticleId IdType="pmc">PMC8411068</ArticleId><ArticleId IdType="pubmed">34474811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitkäniemi J., Malila N., Tanskanen T., Degerlund H., Heikkinen S., Seppä K. Cancer in Finland 2020. Cancer Society of Finland; Helsinki, Finland: 2022.</Citation></Reference><Reference><Citation>Reinwald F., Justenhoven C. Impact of the COVID-19 Pandemic on Number and Stages of Tumors–Data of a German Cancer Registry. Acta Oncol. (Madr.) 2023;62:315–317. doi: 10.1080/0284186X.2023.2187259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0284186X.2023.2187259</ArticleId><ArticleId IdType="pubmed">36905643</ArticleId></ArticleIdList></Reference><Reference><Citation>Englum B.R., Prasad N.K., Lake R.E., Mayorga-Carlin M., Turner D.J., Siddiqui T., Sorkin J.D., Lal B.K. Impact of the COVID-19 Pandemic on Diagnosis of New Cancers: A National Multicenter Study of the Veterans Affairs Healthcare System. Cancer. 2022;128:1048–1056. doi: 10.1002/cncr.34011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.34011</ArticleId><ArticleId IdType="pmc">PMC8837676</ArticleId><ArticleId IdType="pubmed">34866184</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojanowski M., Radomyski P., Kycler W., Michalek I.M. The Impact of the COVID-19 Pandemic on Incidence Gap in Screen-Detectable Cancers: A Cohort Study in Greater Poland, Poland. Rep. Pract. Oncol. Radiother. 2024;29:131–140. doi: 10.5603/rpor.99354.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/rpor.99354</ArticleId><ArticleId IdType="pmc">PMC11321766</ArticleId><ArticleId IdType="pubmed">39143965</ArticleId></ArticleIdList></Reference><Reference><Citation>University Hospital Zurich  Prostatakrebs: Bessere Früherkennung Dank Neuem Test.  [(accessed on 19 June 2024)].  Available online:  https://www.usz.ch/neue-generation-der-prostatakrebsdiagnose/</Citation></Reference><Reference><Citation>Federal Statistical Office  Lebenserwartung, 2000–2022.  [(accessed on 20 June 2024)].  Available online:  https://www.bfs.admin.ch/bfs/de/home/statistiken/bevoelkerung/geburten-todesfaelle/lebenserwartung.assetdetail.27225455.html.</Citation></Reference><Reference><Citation>International Organization for Migration  World Migration Report 2024—Chapter 3: Migration and Migrants: Regional Dimensions and Developments—Europe.  [(accessed on 20 June 2024)].  Available online:  https://worldmigrationreport.iom.int/what-we-do/world-migration-report-2024-chapter-3/europe.</Citation></Reference><Reference><Citation>Federal Statistical Office  Hospitalisierungen Mit COVID-19-Diagnose 2020 Und 2021.  [(accessed on 18 September 2024)].  Available online:  https://www.swissstats.bfs.admin.ch/collection/ch.admin.bfs.swissstat.de.issue221421702100/article/issue221421702100-01.</Citation></Reference><Reference><Citation>Thiabaud A., Iten A., Balmelli C., Senn L., Troillet N., Widmer A., Flury D., Schreiber P.W., Vázquez M., Damonti L., et al. Cohort Profile: SARS-CoV-2/COVID-19 Hospitalised Patients in Switzerland. Swiss Med. Wkly. 2021;151:w20475. doi: 10.4414/smw.2021.20475.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2021.20475</ArticleId><ArticleId IdType="pubmed">33638351</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Statistical Office  Sterblichkeit, Todesursachen—Entwicklung Der Anzahl Todesfälle Und Der Sterberate, Sterblichkeit Im Laufe Des Jahres, Sterblichkeit Nach Alter Und Geschlecht.  [(accessed on 18 September 2024)].  Available online:  https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/gesundheitszustand/sterblichkeit-todesursachen.html.</Citation></Reference><Reference><Citation>Voigtländer S., Hakimhashemi A., Grundmann N., Radespiel-Tröger M., Inwald E.C., Ortmann O., Gerken M., Klug S.J., Klinkhammer-Schalke M., Meyer M., et al. Impact of the COVID-19 Pandemic on Reported Cancer Diagnoses in Bavaria, Germany. J. Cancer Res. Clin. Oncol. 2023;149:7493–7503. doi: 10.1007/s00432-023-04707-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-023-04707-0</ArticleId><ArticleId IdType="pmc">PMC10038367</ArticleId><ArticleId IdType="pubmed">36964405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltofen T., Hagemann F., Harbeck N., Wuerstlein R., Kost B.P., Burges A., Mahner S., Trillsch F. Changes in Gynecologic and Breast Cancer Diagnoses during the First Wave of the COVID-19 Pandemic: Analysis from a Tertiary Academic Gyneco-Oncological Center in Germany. Arch. Gynecol. Obstet. 2022;305:713–718. doi: 10.1007/s00404-021-06211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-021-06211-7</ArticleId><ArticleId IdType="pmc">PMC8422832</ArticleId><ArticleId IdType="pubmed">34491417</ArticleId></ArticleIdList></Reference><Reference><Citation>Gysling S., Morgan H., Ifesemen O.S., West D., Conibear J., Navani N., O’Dowd E.L., Baldwin D.R., Humes D., Hubbard R. The Impact of COVID-19 on Lung Cancer Incidence in England: Analysis of the National Lung Cancer Audit 2019 and 2020 Rapid Cancer Registration Datasets. Chest. 2023;163:1599–1607. doi: 10.1016/j.chest.2023.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2023.01.008</ArticleId><ArticleId IdType="pmc">PMC9833851</ArticleId><ArticleId IdType="pubmed">36640995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>